堃博医疗-B(02216)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02216 堃博医疗-B

未开盘 02-01 16:08:35

2.390

+0.020

+0.84%

最高2.460	最低2.350	成交量39.00万
今开2.380	昨收2.370	日振幅4.64%
总市值12.59亿	流通市值12.59亿	总股本5.27亿
成交额93.37万	换手率0.07%	流通股本5.27亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02216","market":"HK","secType":"STK","nameCN":"堃博医疗-B","latestPrice":2.39,"timestamp":1675238915015,"preClose":2.37,"halted":0,"volume":390000,"delay":0,"floatShares":526873076,"shares":526873076,"eps":-6.184699,"marketStatus":"未开盘","marketStatusCode":0,"change":0.02,"latestTime":"02-01 16:08:35","open":2.38,"high":2.46,"low":2.35,"amount":933715,"amplitude":0.046414,"askPrice":2.46,"askSize":50000,"bidPrice":2.36,"bidSize":24500,"shortable":0,"etf":0,"ttmEps":-3.8251346836991558,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1675301400000},"adr":0,"listingDate":1632412800000,"adjPreClose":2.37,"volumeRatio":1.7520215621617108,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02216","defaultTab":"news","newsList":[{"id":"2306545403","title":"堃博医疗-B盘中异动 急速跳水5.54%报2.371港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2306545403","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2306545403?lang=zh_CN&edition=full","pubTime":"2023-01-26 14:10","pubTimestamp":1674713409,"startTime":"0","endTime":"0","summary":"2023年01月26日下午盘14时10分，堃博医疗-B股票出现波动，股价快速下跌5.54%。截至发稿，该股报2.371港元/股，成交量26.6万股，换手率0.05%，振幅7.17%。资金方面，该股资金流入13.8755万港元，流出28.8855万港元。堃博医疗-B股票所在的医疗保健设备行业中，整体涨幅为0.37%。该公司的业务包括提供诊断解决方案、肺癌治疗解决方案、慢性阻塞性肺病解决方案和导航平台。肺癌治疗解决方案产品包括针对肺癌的InterVapor和H-Marker等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230126141009846d4066&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230126141009846d4066&s=b","is_publish_highlight":false},{"id":"2304654495","title":"堃博医疗-B盘中异动 急速跳水5.12%报2.411港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2304654495","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2304654495?lang=zh_CN&edition=full","pubTime":"2023-01-17 10:25","pubTimestamp":1673922339,"startTime":"0","endTime":"0","summary":"2023年01月17日早盘10时25分，堃博医疗-B股票出现波动，股价快速下跌5.12%。截至发稿，该股报2.411港元/股，成交量22.05万股，换手率0.04%，振幅5.51%。资金方面，该股资金流入22.7625万港元，流出23.942万港元。堃博医疗-B股票所在的医疗保健设备行业中，整体跌幅为0.51%。该公司的业务包括提供诊断解决方案、肺癌治疗解决方案、慢性阻塞性肺病解决方案和导航平台。肺癌治疗解决方案产品包括针对肺癌的InterVapor和H-Marker等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202301171025398349bcaa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202301171025398349bcaa&s=b","is_publish_highlight":false},{"id":"2303967820","title":"堃博医疗-B盘中异动 股价大涨6.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2303967820","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2303967820?lang=zh_CN&edition=full","pubTime":"2023-01-13 14:12","pubTimestamp":1673590374,"startTime":"0","endTime":"0","summary":"2023年01月13日下午盘14时12分，堃博医疗-B股票出现波动，股价急速上涨6.12%。堃博医疗-B股票所在的医疗保健设备行业中，整体涨幅为0.85%。其相关个股中，诺辉健康-B、心通医疗-B、复锐医疗科技涨幅较大，振幅较大的相关个股有心通医疗-B、诺辉健康-B、智云健康，振幅分别为12.70%、12.26%、12.15%。堃博医疗-B公司简介：堃博医疗控股有限公司是一家提供创新型肺部疾病解决方案的中国投资控股公司。肺癌治疗解决方案产品包括针对肺癌的InterVapor和H-Marker等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230113141255846d2449&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230113141255846d2449&s=b","is_publish_highlight":false},{"id":"2302039618","title":"堃博医疗-B(02216.HK)涨超13%，截至发稿，涨10.28%，报2.36港元，成交额187.74万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2302039618","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2302039618?lang=zh_CN&edition=full","pubTime":"2023-01-10 11:20","pubTimestamp":1673320826,"startTime":"0","endTime":"0","summary":"截至2023年1月9日收盘，堃博医疗-B报收于2.14元，下跌2.73%，换手率0.26%，成交量138.55万股，成交额294.47万元。投行对该股关注度不高，90天内无投行对其给出评级。堃博医疗-B港股市值11.28亿港元，在医疗器械Ⅱ行业中排名第21。主要指标见下表：以上内容由证券之星根据公开信息整理，与本站立场无关。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"https://stock.stockstar.com/RB2023011000003474.shtml","is_publish_highlight":false},{"id":"2302203679","title":"港股异动 | 堃博医疗-B(02216)涨超13% 与呼研院就肺部射频消融系统项目&可调弯支气管镜鞘管项目签订战略合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2302203679","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2302203679?lang=zh_CN&edition=full","pubTime":"2023-01-10 11:12","pubTimestamp":1673320376,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，堃博医疗-B(02216)涨超13%，截至发稿，涨10.28%，报2.36港元，成交额187.74万港元。消息面上，堃博医疗官方公众号发布消息称，近日，堃博医疗与广州呼吸健康研究院（简称“呼研院”）就肺部射频消融系统项目&可调弯支气管镜鞘管项目签署医工转化战略合作协约书。双方将会立足于各自的医疗资源与技术平台优势，建立全方位、广覆盖、多元化的合作体系，积极推动医工深度融合和技术创新，开创肺癌介入治疗新纪元。华泰证券此前发研报称，公司导航产品性能行业领先，销售网络建设，以及积极推进肺部导航系统的本土化生产，看好其持续放量。该行维持“买入”评级，给予目标价6.1港币。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://www.zhitongcaijing.com/content/detail/859536.html","is_publish_highlight":false},{"id":"2302385700","title":"堃博医疗-B盘中异动 早盘股价大涨5.14%报2.251港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2302385700","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2302385700?lang=zh_CN&edition=full","pubTime":"2023-01-10 09:38","pubTimestamp":1673314717,"startTime":"0","endTime":"0","summary":"2023年01月10日早盘09时38分，堃博医疗-B股票出现波动，股价大幅上涨5.14%。截至发稿，该股报2.251港元/股，成交量3.1万股，换手率0.01%，振幅2.80%。资金方面，该股资金流入5.9625万港元，流出8870港元。堃博医疗-B股票所在的医疗保健设备行业中，整体跌幅为0.26%。堃博医疗-B公司简介：堃博医疗控股有限公司是一家提供创新型肺部疾病解决方案的中国投资控股公司。肺癌治疗解决方案产品包括针对肺癌的InterVapor和H-Marker等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230110093838834851ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20230110093838834851ee&s=b","is_publish_highlight":false},{"id":"2302074873","title":"堃博医疗-B盘中异动 早盘快速跳水7.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2302074873","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2302074873?lang=zh_CN&edition=full","pubTime":"2023-01-09 09:37","pubTimestamp":1673228234,"startTime":"0","endTime":"0","summary":"2023年01月09日早盘09时37分，堃博医疗-B股票出现异动，股价快速下跌7.77%。堃博医疗-B股票所在的医疗保健设备行业中，整体跌幅为0.14%。其相关个股中，诺辉健康-B、微创医疗、心通医疗-B涨幅较大，振幅较大的相关个股有康基医疗、沛嘉医疗-B、智云健康，振幅分别为0.00%、0.00%、0.00%。堃博医疗-B公司简介：堃博医疗控股有限公司是一家提供创新型肺部疾病解决方案的中国投资控股公司。肺癌治疗解决方案产品包括针对肺癌的InterVapor和H-Marker等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202301090937158060d52d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202301090937158060d52d&s=b","is_publish_highlight":false},{"id":"2285805394","title":"堃博医疗-B(02216.HK)显著活跃，午后升约12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2285805394","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2285805394?lang=zh_CN&edition=full","pubTime":"2022-11-24 14:20","pubTimestamp":1669270835,"startTime":"0","endTime":"0","summary":"高盛、华泰等维持“买入”评级。截至发稿，堃博医疗涨12.25%，报2.20港元，市值11.59亿港元。截至2022年11月23日收盘，堃博医疗-B报收于1.96元，上涨0.51%，换手率0.17%，成交量88.55万股，成交额178.65万元。投行对该股的评级以买入为主，近90天内共有1家投行给出买入评级，近90天的目标均价为6.1。华泰证券最新一份研报给予堃博医疗-B买入评级，目标价6.1。机构评级详情见下表：堃博医疗-B港股市值10.32亿港元，在医疗器械Ⅱ行业中排名第20。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"https://stock.stockstar.com/RB2022112400003690.shtml","is_publish_highlight":false},{"id":"2285037418","title":"港股异动 | 堃博医疗-B(02216)升12% InterVapor产品销售稳步增长 机构维持“买入”","url":"https://stock-news.laohu8.com/highlight/detail?id=2285037418","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2285037418?lang=zh_CN&edition=full","pubTime":"2022-11-24 14:08","pubTimestamp":1669270095,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，堃博医疗-B显著活跃，午后升约12%。公司强调，旗下InterVapor产品销售稳步增长。截至发稿，堃博医疗涨12.25%，报2.20港元，市值11.59亿港元。本周，高盛发布堃博医疗更新报告称，公司管理层指，旗下InterVapor产品在医院招标、定价、注册和通过KOL/医生进行营销方面取得了稳步进展。23财年，预计其实现至少80%的销售同比增长。今年3月，公司用于治疗COPD的热蒸汽消融产品InterVapor在国内获批上市。给予目标价6.10港币，维持“买入”评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://www.zhitongcaijing.com/content/detail/836574.html","is_publish_highlight":false},{"id":"2285725018","title":"【券商聚焦】高盛维持堃博医疗-B(02216)“买入”评级 料InterVapor销售额23财年回升","url":"https://stock-news.laohu8.com/highlight/detail?id=2285725018","media":"凤凰网港股","top":-1,"share":"https://www.laohu8.com/m/news/2285725018?lang=zh_CN&edition=full","pubTime":"2022-11-21 10:36","pubTimestamp":1668998214,"startTime":"0","endTime":"0","summary":"高盛发布研究报告指出，堃博医疗-B管理层强调了其InterVapor在医院招标、定价、注册和通过KOL/医生进行营销方面取得了稳步进展，将2022财年的销售指引下调了10%，原因是疫情致医院招标进度放缓，不过预计商业化将回到正轨，在23财年实现至少80%的销售同比增长。该行预计，InterVapor的销售额23财年回升。InterVapor自2022年6月推出产品以来，已进入30家医院，于5家医院销售系统，于25家医院租赁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"source_url":"http://hknews.szfuit.com/newRssInfo/feed?original_id=8e16744934feb089cf93706f895dcb57","is_publish_highlight":false},{"id":"2282263239","title":"堃博医疗-B(02216.HK)再涨超23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2282263239","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2282263239?lang=zh_CN&edition=full","pubTime":"2022-11-09 11:02","pubTimestamp":1667962951,"startTime":"0","endTime":"0","summary":"截至发稿，涨23.46%，报2.21港元，成交额279.81万港元。截至2022年11月8日收盘，堃博医疗-B报收于1.79元，上涨9.15%，换手率0.16%，成交量83.75万股，成交额150.39万元。投行对该股的评级以买入为主，近90天内共有1家投行给出买入评级，近90天的目标均价为6.1。华泰证券最新一份研报给予堃博医疗-B买入评级，目标价6.1。机构评级详情见下表：堃博医疗-B港股市值9.43亿港元，在医疗器械Ⅱ行业中排名第21。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"https://stock.stockstar.com/RB2022110900002818.shtml","is_publish_highlight":false},{"id":"2282925454","title":"港股异动 | 堃博医疗-B(02216)再涨超23% 与怡亚通达成战略合作 进一步开拓肺部介入诊疗产品市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2282925454","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2282925454?lang=zh_CN&edition=full","pubTime":"2022-11-09 10:50","pubTimestamp":1667962212,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，堃博医疗-B(02216)再涨超23%。截至发稿，涨23.46%，报2.21港元，成交额279.81万港元。消息面上，近日，堃博医疗与中国供应链服务龙头企业怡亚通达成战略合作伙伴关系，充分发挥双方的核心优势，以合作平台整合资源，优势互补，提高竞争力，怡亚通将以专业供应链服务助力堃博医疗的肺部介入诊疗产品覆盖更广阔的市场。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://www.zhitongcaijing.com/content/detail/826768.html","is_publish_highlight":false},{"id":"2281959292","title":"堃博医疗(02216.HK)午前涨超13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2281959292","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2281959292?lang=zh_CN&edition=full","pubTime":"2022-11-08 11:50","pubTimestamp":1667879423,"startTime":"0","endTime":"0","summary":"截至发稿，涨10.37%，报1.81港元，总市值9.53亿港元。截至2022年11月7日收盘，堃博医疗-B报收于1.64元，上涨4.46%，换手率0.17%，成交量86.95万股，成交额144.66万元。投行对该股的评级以买入为主，近90天内共有1家投行给出买入评级，近90天的目标均价为6.1。华泰证券最新一份研报给予堃博医疗-B买入评级，目标价6.1。机构评级详情见下表：堃博医疗-B港股市值8.64亿港元，在医疗器械Ⅱ行业中排名第22。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"https://stock.stockstar.com/RB2022110800003256.shtml","is_publish_highlight":false},{"id":"2281596499","title":"港股异动 | 堃博医疗(02216)大涨13% 与怡亚通达成战略合作 有望推动医疗器械物流的高效集成管控与优化","url":"https://stock-news.laohu8.com/highlight/detail?id=2281596499","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2281596499?lang=zh_CN&edition=full","pubTime":"2022-11-08 11:38","pubTimestamp":1667878681,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，堃博医疗午前涨超13%。本次合作将大大提高堃博医疗产品贮运安全性及响应速度。堃博医疗与怡亚通在全国的合作正在稳步推进中，通过战略合作推动医疗器械物流的高效集成管控与优化。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://www.zhitongcaijing.com/content/detail/825741.html","is_publish_highlight":false},{"id":"2279242538","title":"堃博医疗-B(02216)：一次性使用内窥镜雾化微导管在中国获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2279242538","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2279242538?lang=zh_CN&edition=full","pubTime":"2022-10-31 08:19","pubTimestamp":1667175549,"startTime":"0","endTime":"0","summary":"智通财经APP讯，堃博医疗-B 公告，2022年10月28日，公司药械结合领域的创新产品“雾泉TM”一次性使用内窥镜雾化微导管正式获得浙江省药品监督管理局批准上市。该产品是截至目前中国唯一获批的雾化微导管，拥有多项专利技术，适应症广，可适配多类药物，开辟肺部疾病治疗领域广泛的药械结合应用场景。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://www.zhitongcaijing.com/content/detail/819463.html","is_publish_highlight":false},{"id":"2277220347","title":"堃博医疗-B盘中异动 早盘急速拉升5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2277220347","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2277220347?lang=zh_CN&edition=full","pubTime":"2022-10-24 09:34","pubTimestamp":1666575256,"startTime":"0","endTime":"0","summary":"2022年10月24日早盘09时34分，堃博医疗-B股票出现波动，股价急速拉升5.13%。堃博医疗-B股票所在的医疗保健设备行业中，整体涨幅为0.03%。其相关个股中，堃博医疗-B、爱康医疗、威高股份涨幅较大，振幅较大的相关个股有康基医疗、沛嘉医疗-B、智云健康，振幅分别为0.00%、0.00%、0.00%。堃博医疗-B公司简介：堃博医疗控股有限公司是一家提供创新型肺部疾病解决方案的中国投资控股公司。肺癌治疗解决方案产品包括针对肺癌的InterVapor和H-Marker等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20221024093416805c9343&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20221024093416805c9343&s=b","is_publish_highlight":false},{"id":"2277119734","title":"堃博医疗-B盘中异动 早盘快速跳水5.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2277119734","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2277119734?lang=zh_CN&edition=full","pubTime":"2022-10-20 09:39","pubTimestamp":1666229983,"startTime":"0","endTime":"0","summary":"2022年10月20日早盘09时39分，堃博医疗-B股票出现异动，股价大幅跳水5.61%。机构评级方面，在所有3家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。堃博医疗-B股票所在的医疗保健设备行业中，整体跌幅为0.07%。堃博医疗-B公司简介：堃博医疗控股有限公司是一家提供创新型肺部疾病解决方案的中国投资控股公司。肺癌治疗解决方案产品包括针对肺癌的InterVapor和H-Marker等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20221020093943829aeea3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20221020093943829aeea3&s=b","is_publish_highlight":false},{"id":"2275600157","title":"堃博医疗-B盘中异动 股价大涨7.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2275600157","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2275600157?lang=zh_CN&edition=full","pubTime":"2022-10-14 11:22","pubTimestamp":1665717748,"startTime":"0","endTime":"0","summary":"2022年10月14日早盘11时22分，堃博医疗-B股票出现波动，股价急速上涨7.98%。堃博医疗-B股票所在的医疗保健设备行业中，整体涨幅为0.71%。其相关个股中，微创机器人-B、微创医疗、复锐医疗科技涨幅较大，振幅较大的相关个股有启明医疗-B、微创机器人-B、微创医疗，振幅分别为11.69%、11.61%、10.36%。堃博医疗-B公司简介：堃博医疗控股有限公司是一家提供创新型肺部疾病解决方案的中国投资控股公司。肺癌治疗解决方案产品包括针对肺癌的InterVapor和H-Marker等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20221014112228805c1b8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20221014112228805c1b8c&s=b","is_publish_highlight":false},{"id":"2264278008","title":"也┮搅(02216.HK)参加2022香港交易所生物科技医药峰会","url":"https://stock-news.laohu8.com/highlight/detail?id=2264278008","media":"金融界网站","top":-1,"share":"https://www.laohu8.com/m/news/2264278008?lang=zh_CN&edition=full","pubTime":"2022-09-02 14:03","pubTimestamp":1662098611,"startTime":"0","endTime":"0","summary":"2022香港交易所生物科技峰会于昨日举行，也┮搅作为肺部疾病介入诊疗领域代表企业出席峰会，CEO湛国威先生介绍了公司在肺部慢病管理上的解决方案。　　本次峰会为香港交易所举办的第五届生物医药峰会，汇聚多位全球医疗行业的专家、科学家、企业高管以及专业投资人，聚焦多个医疗健康领域焦点议题，受到资本界广泛关注。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://hk.jrj.com.cn/2022/09/02140336967316.shtml","is_publish_highlight":false},{"id":"2263473806","title":"堃博医疗（02216.HK）公布2022年上半年度业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2263473806","media":"美通社","top":-1,"share":"https://www.laohu8.com/m/news/2263473806?lang=zh_CN&edition=full","pubTime":"2022-08-31 14:49","pubTimestamp":1661928540,"startTime":"0","endTime":"0","summary":"2022年上半年营业收入同比增长12.8%，亏损缩窄62.8%，逐步形成肺部重大疾病“诊断+治疗+慢病管理”的闭环模式 杭州2022年8月31日 /美通社/ -- 2022年8月30日，中国肺部疾病精准介入诊疗领导者堃博医疗公布截至2022年6月30日止六个月 的中期业绩。该产品上市前临床试验已完成6个月随访，预计将于2024年第一季度获得NMPA注册，正式开启商业化应用。InterVapor自2021年开始在杭州生产，预计2022年底完成生产流程转移。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"https://wwwold.prnasia.com/story/archive/3859413_ZH59413_1","is_publish_highlight":false}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0478},{"period":"1month","weight":0.0437},{"period":"3month","weight":0.5321},{"period":"6month","weight":-0.0808},{"period":"1year","weight":-0.6323},{"period":"ytd","weight":0.0437}],"websiteUrl":"http://www.broncus.com","compareEarnings":[{"period":"1week","weight":0.0012},{"period":"1month","weight":0.1158},{"period":"3month","weight":0.4389},{"period":"6month","weight":0.0926},{"period":"1year","weight":-0.0727},{"period":"ytd","weight":0.1158}],"name":"堃博医疗-B","description":"堃博医疗控股有限公司是一家提供创新型肺部疾病解决方案的中国投资控股公司。该公司的业务包括提供诊断解决方案、肺癌治疗解决方案、慢性阻塞性肺病解决方案和导航平台。诊断解决方案的产品包括FleXNeedle，ATV鞘管和ATV球囊等。肺癌治疗解决方案产品包括针对肺癌的InterVapor和H-Marker等。慢性阻塞性肺病解决方案产品包括针对慢性阻塞性肺病的InterVapor和靶向肺去神经消融系统。导航平台产品包括Lungpoint，Lungpro，和新一代导航系统等。","exchange":"SEHK","nameEN":"BRONCUS-B","compareStock":{"symbol":"HSI","name":"恒生指数"}},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.11.11","shortVersion":"4.11.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"堃博医疗-B(02216)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供堃博医疗-B(02216)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"堃博医疗-B,02216,堃博医疗-B股票,堃博医疗-B股票老虎,堃博医疗-B股票老虎国际,堃博医疗-B行情,堃博医疗-B股票行情,堃博医疗-B股价,堃博医疗-B股市,堃博医疗-B股票价格,堃博医疗-B股票交易,堃博医疗-B股票购买,堃博医疗-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"堃博医疗-B(02216)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供堃博医疗-B(02216)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}